Wells Fargo’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,502
| Closed | -$181K | – | 7921 |
|
|
2022
Q3 | $181K | Sell |
3,502
-1,157
| -25% | -$47.8K | ﹤0.01% | 4306 |
|
|
2022
Q2 | $115K | Sell |
4,659
-20,428
| -81% | -$450K | ﹤0.01% | 4568 |
|
|
2022
Q1 | $629K | Sell |
25,087
-51,958
| -67% | -$1.46M | ﹤0.01% | 4244 |
|
|
2021
Q4 | $2.81M | Sell |
77,045
-283,524
| -79% | -$9.95M | ﹤0.01% | 3159 |
|
|
2021
Q3 | $6.17M | Buy |
360,569
+227,884
| +172% | +$3.55M | ﹤0.01% | 2642 |
|
|
2021
Q2 | $1.78M | Sell |
132,685
-134,187
| -50% | -$3.31M | ﹤0.01% | 3787 |
|
|
2021
Q1 | $13.7M | Buy |
266,872
+8,737
| +3% | +$526K | ﹤0.01% | 1950 |
|
|
2020
Q4 | $16M | Buy |
258,135
+1,606
| +0.6% | +$91.9K | ﹤0.01% | 1720 |
|
|
2020
Q3 | $14.1M | Buy |
256,529
+118,577
| +86% | +$6.38M | ﹤0.01% | 1660 |
|
|
2020
Q2 | $7.94M | Buy |
137,952
+102,843
| +293% | +$5.6M | ﹤0.01% | 2044 |
|
|
2020
Q1 | $1.41M | Buy |
35,109
+14,521
| +71% | +$617K | ﹤0.01% | 3291 |
|
|
2019
Q4 | $814K | Sell |
20,588
-60,457
| -75% | -$1.06M | ﹤0.01% | 4000 |
|
|
2019
Q3 | $550K | Buy |
81,045
+22,386
| +38% | +$168K | ﹤0.01% | 4303 |
|
|
2019
Q2 | $546K | Sell |
58,659
-68,466
| -54% | -$793K | ﹤0.01% | 4325 |
|
|
2019
Q1 | $1.76M | Buy |
127,125
+59,586
| +88% | +$681K | ﹤0.01% | 3464 |
|
|
2018
Q4 | $737K | Buy |
67,539
+19,376
| +40% | +$204K | ﹤0.01% | 4077 |
|
|
2018
Q3 | $609K | Buy |
48,163
+2,161
| +5% | +$26K | ﹤0.01% | 4303 |
|
|
2018
Q2 | $606K | Sell |
46,002
-6,969
| -13% | -$83.3K | ﹤0.01% | 4320 |
|
|
2018
Q1 | $720K | Buy |
52,971
+4,335
| +9% | +$44.7K | ﹤0.01% | 4142 |
|
|
2017
Q4 | $290K | Buy |
48,636
+14,133
| +41% | +$97K | ﹤0.01% | 4771 |
|
|
2017
Q3 | $255K | Buy |
34,503
+10,908
| +46% | +$90.7K | ﹤0.01% | 4788 |
|
|
2017
Q2 | $221K | Buy |
23,595
+729
| +3% | +$5.35K | ﹤0.01% | 4717 |
|
|
2017
Q1 | $167K | Sell |
22,866
-4,621
| -17% | -$33.3K | ﹤0.01% | 4928 |
|
|
2016
Q4 | $203K | Buy |
27,487
+13,267
| +93% | +$95.5K | ﹤0.01% | 4774 |
|
|
2016
Q3 | $86K | Sell |
14,220
-3,292
| -19% | -$15.6K | ﹤0.01% | 5008 |
|
|
2016
Q2 | $79K | Buy |
17,512
+1,586
| +10% | +$5.95K | ﹤0.01% | 4965 |
|
|
2016
Q1 | $40K | Buy |
15,926
+730
| +5% | +$2.66K | ﹤0.01% | 5307 |
|
|
2015
Q4 | $123K | Sell |
15,196
-656
| -4% | -$4.64K | ﹤0.01% | 4773 |
|
|
2015
Q3 | $96K | Buy |
15,852
+532
| +3% | +$3.85K | ﹤0.01% | 4916 |
|
|
2015
Q2 | $126K | Buy |
15,320
+13,832
| +930% | +$110K | ﹤0.01% | 4903 |
|
|
2015
Q1 | $11K | Buy |
1,488
+219
| +17% | +$1.71K | ﹤0.01% | 5603 |
|
|
2014
Q4 | $9K | Buy |
1,269
+10
| +0.8% | +$53 | ﹤0.01% | 5691 |
|
|
2014
Q3 | $6K | Sell |
1,259
-687
| -35% | -$3.63K | ﹤0.01% | 5789 |
|
|
2014
Q2 | $11K | Buy |
+1,946
| New | +$10.9K | ﹤0.01% | 5612 |
|
Other funds holding CCXI
Wells Fargo's CCXI Position: Q4 2022 in Review
Wells Fargo sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 3,502 shares — an estimated $181K sold.
Wells Fargo first reported a position in CCXI in Q2 2014 and held it in 34 quarters. The position peaked at $16M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Wells Fargo reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Wells Fargo sold 3,502 ChemoCentryx, Inc. shares in Q4 2022, an estimated $181K.
- Wells Fargo first reported a position in ChemoCentryx, Inc. in Q2 2014 and held it in 34 quarters.
- Wells Fargo's ChemoCentryx, Inc. position peaked at $16M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.